Ulrich Guller
Experienced in Lung Metastases

Ulrich Guller

Bern, BE, CH 
Experienced in Lung Metastases
Bern, BE, CH 
OverviewLocationsClinical Research

Overview

Ulrich Guller practices in Bern, Switzerland. Mr. Guller is rated as an Experienced expert by MediFind in the treatment of Lung Metastases. His top areas of expertise are Colorectal Cancer, Hernia, Sclerosing Mesenteritis, Bone Marrow Aspiration, and Gallbladder Removal.

His clinical research consists of co-authoring 67 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of Lung Metastases.

Gender
Male

Locations

Bern, BE, Switzerland
Other Locations
Spital STS AG
Thun, BE, Switzerland
Spital STS Thun, Schlieren / Spital, ZH, Switzerland
Kantonsspital St. Gallen, Sankt Gallen, SG 9007, Switzerland
Kantonsspital St Gallen, Switzerland
Kantonsspital Frauenfeld, Spital Thurgau AG
Frauenfeld, TG 8500, Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Adjuvant Aspirin Treatment in PIK3CA Mutated Colon Cancer Patients. A Randomized, Double-blinded, Placebo-controlled, Phase III Trial
Adjuvant Aspirin Treatment in PIK3CA Mutated Colon Cancer Patients. A Randomized, Double-blinded, Placebo-controlled, Phase III Trial
Enrollment Status: Terminated
Publish Date: May 16, 2025
Intervention Type: Drug
Study Drug: Aspirin
Study Phase: Phase 3
Prospective Cohort Study With Collection of Clinical Data, Serum and Plasma of Patients With Prostate Disease
Prospective Cohort Study With Collection of Clinical Data, Serum and Plasma of Patients With Prostate Disease
Enrollment Status: Active_not_recruiting
Publish Date: June 08, 2022
Intervention Type: Other
View 1 Less Clinical Trial

67 Total Publications

Adjuvant Aspirin Treatment in PIK3CA-Mutated Colon Cancer Patients: The SAKK 41/13 Prospective Randomized Placebo-Controlled Double-Blind Trial.
Adjuvant Aspirin Treatment in PIK3CA-Mutated Colon Cancer Patients: The SAKK 41/13 Prospective Randomized Placebo-Controlled Double-Blind Trial.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 05, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Guller's expertise for a condition
ConditionClose
      View All 18 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile